Topiramate in treatment of Tourette syndrome

Clinical Neuropharmacology

Volumn 33, Issue 1, 2010, Pages 32-34

  Kuo, Sheng Han ^a   Jimenez Shahed, Joohi ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Tics; Topiramate; Tourette syndrome

Indexed keywords

BOTULINUM TOXIN; CLONIDINE; GUANFACINE; TETRABENAZINE; TOPIRAMATE;

ADOLESCENT; AGGRESSION; ARTICLE; CHILD; CLINICAL ARTICLE; COGNITIVE DEFECT; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GILLES DE LA TOURETTE SYNDROME; HUMAN; LANGUAGE DISABILITY; MALE; MEDICAL RECORD REVIEW; MOOD; MOOD DISORDER; OUTPATIENT DEPARTMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SIDE EFFECT; THERAPY EFFECT; TIC; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; WEIGHT REDUCTION;

ADOLESCENT; ADULT; CHILD; FEMALE; FRUCTOSE; HUMANS; LONGITUDINAL STUDIES; MALE; NEUROPROTECTIVE AGENTS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TOURETTE SYNDROME; TREATMENT OUTCOME; YOUNG ADULT;

EID: 76749113824     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e3181c295c1     Document Type: Article

References (15)

1. Jankovic J. Tourette's s-ndrome. N Engl J Med 2001;345:1184-1192.
2. Kenney C, Kuo SH, Jimenez-Shahed J. Tourette's syndrome. Am Fam Physician 2008;77:651-658.
3. Robertson MM. Tourette syndrome, associated conditions and the complexities of treatment. Brain 2000;123(Pt 3):425-462.
4. Abuzzahab FS, Brown VL. Control of Tourette's syndrome with topiramate. Am J Psychiatry 2001;158:968.
5. The Tourette Syndrome Classification Study Group. Definitions and classification of tic disorders. The Tourette Syndrome Classification Study Group. Arch Neurol 1993;50:1013-1016.
6. Sallee FR, Nesbitt L, Jackson C, et al. Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder. Am J Psychiatry 1997;154:1057-1062.
7. Jankovic J, Beach J. Long-term effects of tetrabenazine in hyperkinetic movement disorders. Neurology 1997;48:358-362.
8. Kwak CH, Hanna PA, Jankovic J. Botulinum toxin in the treatment of tics. Arch Neurol 2000;57:1190-1193.
9. Shahed J, Poysky J, Kenney C, et al. GPi deep brain stimulation for Tourette syndrome improves tics and psychiatric comorbidities. Neurology 2007;68:159-160.
10. Albin RL, Mink JW. Recent advances in Tourette syndrome research. Trends Neurosci 2006;29:175-182.
11. Leckman JF, Vaccarino FM, Kalanithi PS, et al. Annotation: Tourette syndrome: a relentless drumbeatVdriven by misguided brain oscillations. J Child Psychol Psychiatry 2006;47:537-550.
12. Kalanithi PS, Zheng W, Kataoka Y, et al. Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proc Natl Acad Sci U S A 2005;102:13307-13312.
13. Arnone D. Review of the use of Topiramate for treatment of psychiatric disorders. Ann Gen Psychiatry 2005;4:5.
14. Glauser TA, Dlugos DJ, Dodson WE, et al. Topiramate monotherapy in newly diagnosed epilepsy in children and adolescents. J Child Neurol 2007;22:693-699.
15. Lakshmi CV, Singhi P, Malhi P, et al. Topiramate in the prophylaxis of pediatric migraine: a double-blind placebo-controlled trial. J Child Neurol 2007;22:829-835.